Oramed CEO Nadav Kidron on CNBC: Oral insulin to be a gamechanger

Oral insulin to be a game changer: Oramed CEO Nadav Kidron tells CNBC

On Squawk Box Asia, Kidron talks about the company’s latest offering

 

You may also be interested

Medical Daily: First Oral Insulin Drug Gains FDA Approval To Begin Testing
Linkedin-in Facebook-f Twitter Youtube

Copyright © 2022 Oramed. | Terms & Conditions | Privacy Statement | Cookie Policy

Join our mailing list

Linkedin-in Facebook-f Twitter Youtube
Home
About
Technology
Pipeline
Video Library
Contact us
NEWS
Press Releases
In the News
Scientific Articles and Abstracts
Events & Presentations
INVESTORS
Corporate presentation
Investor Relations
SEC filings
Investor FAQ
Governance documents
Annual shareholder meeting
Investor tools
Oravax Medical
Skip to content